01—Abstract
Summary
Summary of the 6-K filed December 23, 2025. Cited figures are marked; the original filing is the authoritative source.
This Form 6-K from James Hardie Industries plc furnishes ASX-required notices covering equity issuances and director interest changes, all dated around mid-December 2025.
The filing reports the issue of 48,957 ordinary shares on 15 December 2025 at USD 0.6924 per share and 212,314 ordinary shares on 16 December 2025 at USD 0.6933 per share. The filing states these shares were issued in respect of the settlement of certain AZEK equity awards outstanding at the closing of the AZEK merger, which was consummated on July 1, 2025. A further 15,525 ordinary shares were issued on 15 December 2025 under the James Hardie 2020 Non-Executive Director Equity Plan.
Following these issuances, the filing lists 430,398,108 CHESS Depositary Interests (quoted on ASX) on issue, 5,195,479 restricted stock units, 269,221 options expiring 3 November 2027 at an exercise price of USD 33.05, and 149,420,368 unquoted ordinary shares as of the latest notice. The filing states that the company applied for, and ASX granted on 16 July 2025, a waiver from Listing Rule 2.4 for the issuance of these unquoted securities. The filing also includes Appendix 3Y change of director's interest notices for eight non-executive directors (Persio V.
Lisboa, Nigel Stein, Suzanne B. Rowland, Renee Peterson, John C.
Pfeifer, Howard Heckes, Jesse Singh and Gary Hendrickson). Each reports an acquisition of ordinary shares effective 15 December 2025 pursuant to the 2020 Non-Executive Director Equity Plan, with no disposals and no trades during a closed period requiring prior written clearance.
02—Key points
Key Highlights
- Issued 48,957 ordinary shares on 15 December 2025 at USD 0.6924 per share, notified to ASX on 18 December 2025, tied to settlement of AZEK equity awards from the merger consummated July 1, 2025.
- Issued 212,314 ordinary shares on 16 December 2025 at USD 0.6933 per share, also tied to settlement of AZEK equity awards outstanding at the merger closing.
- Issued 15,525 ordinary shares on 15 December 2025 under the James Hardie 2020 Non-Executive Director Equity Plan.
- Post-issuance count as stated in the filing: 430,398,108 quoted CHESS Depositary Interests, 5,195,479 restricted stock units, and 269,221 options expiring 3 November 2027 (exercise price USD 33.05).
- Eight non-executive directors each acquired ordinary shares effective 15 December 2025 under the 2020 Non-Executive Director Equity Plan, with no disposals reported.
- Director acquisitions ranged from 777 shares (Suzanne B. Rowland, US$14,312.34) to 4,599 shares (Gary Hendrickson, US$86,441.88).
- ASX granted a waiver from Listing Rule 2.4 on 16 July 2025 for the issuance of these unquoted securities.
03—Questions
Frequently Asked Questions
Why did James Hardie issue new ordinary shares in December 2025?
The filing states that the 48,957 and 212,314 ordinary shares issued on 15 and 16 December 2025 represent shares issued in respect of the settlement of certain AZEK equity awards outstanding as of the closing of the merger on July 1, 2025. The 15,525 shares issued on 15 December 2025 were issued under the 2020 Non-Executive Director Equity Plan.
At what price were the shares issued?
The filing reports an issue price of USD 0.6924 per share for the 48,957 shares issued on 15 December 2025 and USD 0.6933 per share for the 212,314 shares issued on 16 December 2025, with cash consideration paid in US dollars.
Did any directors sell shares?
No. Each of the eight director notices reports nil shares disposed. Each reports only the acquisition of ordinary shares under the 2020 Non-Executive Director Equity Plan, effective 15 December 2025.
How many securities does the company have on issue after these issuances?
The filing lists 430,398,108 quoted CHESS Depositary Interests, 5,195,479 restricted stock units, 269,221 options expiring 3 November 2027, and 149,420,368 unquoted ordinary shares in its most recent Appendix 3G notice.
04—Continue